Rockefeller Capital Management
PDSB icon

Rockefeller Capital Management’s PDS Biotechnology PDSB Stock Holding History

Rockefeller Capital Management’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.4K Hold
27,664
– – ﹤0.01% 3675
2026
Q1 		$16.7K Buy
27,664
+2,000
+8% +$1.5K ﹤0.01% 3784
2025
Q4 		$19.8K Sell
25,664
-8,803
-26% -$7.94K ﹤0.01% 3521
2025
Q3 		$34.8K Buy
+34,467
New +$40.5K ﹤0.01% 3086
2023
Q1 		– Sell
-3,413
Closed -$45K – 3339
2022
Q4 		$45K Buy
+3,413
New +$24.1K ﹤0.01% 2440
2022
Q2 		– Sell
-955
Closed -$5K – 4323
2022
Q1 		$5K Sell
955
-5,730
-86% -$35.6K ﹤0.01% 3347
2021
Q4 		$54K Hold
6,685
– – ﹤0.01% 2185
2021
Q3 		$99K Hold
6,685
– – ﹤0.01% 1866
2021
Q2 		$83K Buy
+6,685
New +$52.2K ﹤0.01% 1875

Other funds holding PDSB

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
MCM
Militia Capital Management Austin, Texas $3.37B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Rockefeller Capital Management's PDSB Position: Q2 2026 in Review

Rockefeller Capital Management held its PDS Biotechnology (PDSB) position steady in Q2 2026 at 27,664 shares worth $24.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3675.

Rockefeller Capital Management first reported a position in PDSB in Q2 2021 and has held it in 9 quarters since. The position peaked at $99K in Q3 2021. 52 funds tracked by Wall St. Rank hold PDSB as of Q2 2026.

  • Rockefeller Capital Management held 27,664 shares of PDS Biotechnology worth $24.4K as of Q2 2026.
  • Rockefeller Capital Management left its PDS Biotechnology share count unchanged in Q2 2026.
  • PDS Biotechnology made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #3675 holding.
  • Rockefeller Capital Management first reported a position in PDS Biotechnology in Q2 2021 and has held it in 9 quarters since.
  • Rockefeller Capital Management's PDS Biotechnology position peaked at $99K in Q3 2021.
  • 52 funds tracked by Wall St. Rank held PDS Biotechnology as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.